APO Research
Talk to an analyst

APO RESEARCH · REPORT

Self-replicating mRNA Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Self-replicating mRNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchSelf-replicating mRNA Vaccines Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Self-replicating mRNA Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Self-replicating mRNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Self-replicating mRNA Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Self-replicating mRNA Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Self-replicating mRNA Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Self-replicating mRNA Vaccines include Aldevron, Arcturus Therapeutics, BioNTech, Chimeron Bio, CSL, Elixirgen Therapeutics, Gritstone Bio, Precision Nanosystems and Replicate Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Self-replicating mRNA Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Self-replicating mRNA Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Self-replicating mRNA Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Self-replicating mRNA Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Self-replicating mRNA Vaccines Segment by Company

Aldevron

Arcturus Therapeutics

BioNTech

Chimeron Bio

CSL

Elixirgen Therapeutics

Gritstone Bio

Precision Nanosystems

Replicate Bioscience

VaxEquity

Ziphius Vaccines

GSK

Immorna

Self-replicating mRNA Vaccines Segment by Type

Preventive Medicine

Medicine

Self-replicating mRNA Vaccines Segment by Application

Infectious Disease

Cancer

Others

Self-replicating mRNA Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self-replicating mRNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Self-replicating mRNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self-replicating mRNA Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Self-replicating mRNA Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Self-replicating mRNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Self-replicating mRNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Self-replicating mRNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Self-replicating mRNA Vaccines Industry Trends Table 2. Self-replicating mRNA Vaccines Industry Drivers Table 3. Self-replicating mRNA Vaccines Industry Opportunities and Challenges Table 4. Self-replicating mRNA Vaccines Industry Restraints Table 5. Global Self-replicating mRNA Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Self-replicating mRNA Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Self-replicating mRNA Vaccines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers Table 9. Global Self-replicating mRNA Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Self-replicating mRNA Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Self-replicating mRNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Self-replicating mRNA Vaccines Manufacturers, Product Type & Application Table 13. Global Self-replicating mRNA Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Self-replicating mRNA Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Preventive Medicine Table 17. Major Manufacturers of Medicine Table 18. Global Self-replicating mRNA Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 20. Global Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 21. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Self-replicating mRNA Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (K Units) Table 25. Global Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (K Units) Table 26. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Infectious Disease Table 29. Major Manufacturers of Cancer Table 30. Major Manufacturers of Others Table 31. Global Self-replicating mRNA Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 33. Global Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 34. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Self-replicating mRNA Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (K Units) Table 38. Global Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (K Units) Table 39. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Self-replicating mRNA Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Self-replicating mRNA Vaccines Sales by Region (2021-2026) & (K Units) Table 43. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Self-replicating mRNA Vaccines Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Self-replicating mRNA Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 48. North America Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 49. Europe Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 51. Europe Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 58. Global Self-replicating mRNA Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Self-replicating mRNA Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Self-replicating mRNA Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2027-2032) Table 63. Aldevron Company Information Table 64. Aldevron Business Overview Table 65. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aldevron Self-replicating mRNA Vaccines Product Portfolio Table 67. Aldevron Recent Development Table 68. Arcturus Therapeutics Company Information Table 69. Arcturus Therapeutics Business Overview Table 70. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 72. Arcturus Therapeutics Recent Development Table 73. BioNTech Company Information Table 74. BioNTech Business Overview Table 75. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. BioNTech Self-replicating mRNA Vaccines Product Portfolio Table 77. BioNTech Recent Development Table 78. Chimeron Bio Company Information Table 79. Chimeron Bio Business Overview Table 80. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio Table 82. Chimeron Bio Recent Development Table 83. CSL Company Information Table 84. CSL Business Overview Table 85. CSL Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CSL Self-replicating mRNA Vaccines Product Portfolio Table 87. CSL Recent Development Table 88. Elixirgen Therapeutics Company Information Table 89. Elixirgen Therapeutics Business Overview Table 90. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 92. Elixirgen Therapeutics Recent Development Table 93. Gritstone Bio Company Information Table 94. Gritstone Bio Business Overview Table 95. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio Table 97. Gritstone Bio Recent Development Table 98. Precision Nanosystems Company Information Table 99. Precision Nanosystems Business Overview Table 100. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio Table 102. Precision Nanosystems Recent Development Table 103. Replicate Bioscience Company Information Table 104. Replicate Bioscience Business Overview Table 105. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio Table 107. Replicate Bioscience Recent Development Table 108. VaxEquity Company Information Table 109. VaxEquity Business Overview Table 110. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. VaxEquity Self-replicating mRNA Vaccines Product Portfolio Table 112. VaxEquity Recent Development Table 113. Ziphius Vaccines Company Information Table 114. Ziphius Vaccines Business Overview Table 115. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio Table 117. Ziphius Vaccines Recent Development Table 118. GSK Company Information Table 119. GSK Business Overview Table 120. GSK Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. GSK Self-replicating mRNA Vaccines Product Portfolio Table 122. GSK Recent Development Table 123. Immorna Company Information Table 124. Immorna Business Overview Table 125. Immorna Self-replicating mRNA Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Immorna Self-replicating mRNA Vaccines Product Portfolio Table 127. Immorna Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Self-replicating mRNA Vaccines Distributors List Table 131. Self-replicating mRNA Vaccines Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Self-replicating mRNA Vaccines Product Image Figure 2. Global Self-replicating mRNA Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Self-replicating mRNA Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Self-replicating mRNA Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Self-replicating mRNA Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Self-replicating mRNA Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Preventive Medicine Image Figure 9. Medicine Image Figure 10. Global Self-replicating mRNA Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Self-replicating mRNA Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Self-replicating mRNA Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Self-replicating mRNA Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Infectious Disease Image Figure 17. Cancer Image Figure 18. Others Image Figure 19. Global Self-replicating mRNA Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Self-replicating mRNA Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Self-replicating mRNA Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Self-replicating mRNA Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Self-replicating mRNA Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Self-replicating mRNA Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Self-replicating mRNA Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Self-replicating mRNA Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Self-replicating mRNA Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Preventive Medicine
  • Medicine
Applications
  • Infectious Disease
  • Cancer
  • Others
Companies covered
  • Aldevron
  • Arcturus Therapeutics
  • BioNTech
  • Chimeron Bio
  • CSL
  • Elixirgen Therapeutics
  • Gritstone Bio
  • Precision Nanosystems
  • Replicate Bioscience
  • VaxEquity
  • Ziphius Vaccines
  • GSK
  • Immorna

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Self-replicating mRNA Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Self-replicating mRNA Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Self-replicating mRNA Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Self-replicating mRNA Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Self-replicating mRNA Vaccines Market Dynamics
  1. 2.1 Self-replicating mRNA Vaccines Industry Trends
  2. 2.2 Self-replicating mRNA Vaccines Industry Drivers
  3. 2.3 Self-replicating mRNA Vaccines Industry Opportunities and Challenges
  4. 2.4 Self-replicating mRNA Vaccines Industry Restraints
3 Self-replicating mRNA Vaccines Market by Manufacturers
  1. 3.1 Global Self-replicating mRNA Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Self-replicating mRNA Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Self-replicating mRNA Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Self-replicating mRNA Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Self-replicating mRNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Self-replicating mRNA Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Self-replicating mRNA Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Self-replicating mRNA Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Self-replicating mRNA Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Self-replicating mRNA Vaccines Tier 1, Tier 2, and Tier 3
4 Self-replicating mRNA Vaccines Market by Type
  1. 4.1 Self-replicating mRNA Vaccines Type Introduction
  2. 4.1.1 Preventive Medicine
  3. 4.1.2 Medicine
  4. 4.2 Global Self-replicating mRNA Vaccines Sales by Type
  5. 4.2.1 Global Self-replicating mRNA Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Self-replicating mRNA Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Self-replicating mRNA Vaccines Revenue by Type
  9. 4.3.1 Global Self-replicating mRNA Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Self-replicating mRNA Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2032)
5 Self-replicating mRNA Vaccines Market by Application
  1. 5.1 Self-replicating mRNA Vaccines Application Introduction
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Cancer
  4. 5.1.3 Others
  5. 5.2 Global Self-replicating mRNA Vaccines Sales by Application
  6. 5.2.1 Global Self-replicating mRNA Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Self-replicating mRNA Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Self-replicating mRNA Vaccines Revenue by Application
  10. 5.3.1 Global Self-replicating mRNA Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Self-replicating mRNA Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2032)
6 Global Self-replicating mRNA Vaccines Sales by Region
  1. 6.1 Global Self-replicating mRNA Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Self-replicating mRNA Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Self-replicating mRNA Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Self-replicating mRNA Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Self-replicating mRNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Self-replicating mRNA Vaccines Revenue by Region
  1. 7.1 Global Self-replicating mRNA Vaccines Revenue by Region
  2. 7.1.1 Global Self-replicating mRNA Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Self-replicating mRNA Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Self-replicating mRNA Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Self-replicating mRNA Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Self-replicating mRNA Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Self-replicating mRNA Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Self-replicating mRNA Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Self-replicating mRNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aldevron
  2. 8.1.1 Aldevron Company Information
  3. 8.1.2 Aldevron Business Overview
  4. 8.1.3 Aldevron Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aldevron Self-replicating mRNA Vaccines Product Portfolio
  6. 8.1.5 Aldevron Recent Developments
  7. 8.2 Arcturus Therapeutics
  8. 8.2.1 Arcturus Therapeutics Company Information
  9. 8.2.2 Arcturus Therapeutics Business Overview
  10. 8.2.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  12. 8.2.5 Arcturus Therapeutics Recent Developments
  13. 8.3 BioNTech
  14. 8.3.1 BioNTech Company Information
  15. 8.3.2 BioNTech Business Overview
  16. 8.3.3 BioNTech Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioNTech Self-replicating mRNA Vaccines Product Portfolio
  18. 8.3.5 BioNTech Recent Developments
  19. 8.4 Chimeron Bio
  20. 8.4.1 Chimeron Bio Company Information
  21. 8.4.2 Chimeron Bio Business Overview
  22. 8.4.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio
  24. 8.4.5 Chimeron Bio Recent Developments
  25. 8.5 CSL
  26. 8.5.1 CSL Company Information
  27. 8.5.2 CSL Business Overview
  28. 8.5.3 CSL Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CSL Self-replicating mRNA Vaccines Product Portfolio
  30. 8.5.5 CSL Recent Developments
  31. 8.6 Elixirgen Therapeutics
  32. 8.6.1 Elixirgen Therapeutics Company Information
  33. 8.6.2 Elixirgen Therapeutics Business Overview
  34. 8.6.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  36. 8.6.5 Elixirgen Therapeutics Recent Developments
  37. 8.7 Gritstone Bio
  38. 8.7.1 Gritstone Bio Company Information
  39. 8.7.2 Gritstone Bio Business Overview
  40. 8.7.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio
  42. 8.7.5 Gritstone Bio Recent Developments
  43. 8.8 Precision Nanosystems
  44. 8.8.1 Precision Nanosystems Company Information
  45. 8.8.2 Precision Nanosystems Business Overview
  46. 8.8.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio
  48. 8.8.5 Precision Nanosystems Recent Developments
  49. 8.9 Replicate Bioscience
  50. 8.9.1 Replicate Bioscience Company Information
  51. 8.9.2 Replicate Bioscience Business Overview
  52. 8.9.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio
  54. 8.9.5 Replicate Bioscience Recent Developments
  55. 8.10 VaxEquity
  56. 8.10.1 VaxEquity Company Information
  57. 8.10.2 VaxEquity Business Overview
  58. 8.10.3 VaxEquity Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 VaxEquity Self-replicating mRNA Vaccines Product Portfolio
  60. 8.10.5 VaxEquity Recent Developments
  61. 8.11 Ziphius Vaccines
  62. 8.11.1 Ziphius Vaccines Company Information
  63. 8.11.2 Ziphius Vaccines Business Overview
  64. 8.11.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio
  66. 8.11.5 Ziphius Vaccines Recent Developments
  67. 8.12 GSK
  68. 8.12.1 GSK Company Information
  69. 8.12.2 GSK Business Overview
  70. 8.12.3 GSK Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GSK Self-replicating mRNA Vaccines Product Portfolio
  72. 8.12.5 GSK Recent Developments
  73. 8.13 Immorna
  74. 8.13.1 Immorna Company Information
  75. 8.13.2 Immorna Business Overview
  76. 8.13.3 Immorna Self-replicating mRNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Immorna Self-replicating mRNA Vaccines Product Portfolio
  78. 8.13.5 Immorna Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Self-replicating mRNA Vaccines Value Chain Analysis
  2. 9.1.1 Self-replicating mRNA Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Self-replicating mRNA Vaccines Production Mode & Process
  6. 9.2 Self-replicating mRNA Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Self-replicating mRNA Vaccines Distributors
  9. 9.2.3 Self-replicating mRNA Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst